Directory
>
Doug Kerr Md
Doug Kerr Md
Board Member and SAB | BlueRock Therapeutics
Boston, Massachusetts, United States
Doug Kerr Md
Summary
Doug Kerr is a distinguished neurologist and neuroscientist based in Boston, Massachusetts, with over 14 years of experience in drug development across various stages. He holds an MD/PhD and an MBA, blending clinical expertise with business acumen. As a founding member of Generation Bio, he has played a pivotal role in advancing gene therapy initiatives. Doug's extensive background includes leadership roles in multiple biotech firms, where he has contributed to the development of innovative therapies for neurodegenerative diseases. He is also an active board member for several organizations, showcasing his commitment to both scientific progress and community engagement. His research interests encompass a wide range of fields, including biochemistry, immunology, and molecular biology, reflecting his multidisciplinary approach to neuroscience. Doug's publications highlight his contributions to understanding acute transverse myelitis and improving therapy development in ALS. He is passionate about leveraging scientific advancements to enhance patient outcomes and drive innovation in the life sciences sector.
Doug Kerr Md
Work Experience
Board Member and SAB at
Trace Neurosciences
May 2024 - Present
Venture Partner at
Atlas Venture
January 2024 - Present
BOD member at
AAVANTGARDE BIO SRL
July 2023 - Present
Board Member at
BlueRock Therapeutics
March 2023 - Present
BOD member at
Genrab Therapeutics
August 2022 - Present
Advisor and LP at
EXCEPTIONAL VENTURES
March 2022 - Present
member SAB and Board at
Siegel Rare Neuroimmune Association
January 2009 - Present
Chief Medical Officer at
Generation Bio
November 2020 - January 2024
BOD member at
Triplet Therapeutics Inc.
July 2019 - December 2023
Chair Compensation Committee at
Faze Medicines
November 2021 - December 2023
Board Member at
Faze Medicines
February 2021 - December 2023
Chief Development Officer at
Generation Bio
March 2019 - November 2020
Scientific Advisory Board Member at
Disarm Therapeutics, Inc.
October 2018 - November 2020
Board of Directors, Chair Science and Medicine Committee at
Curesma
January 2018 - September 2020
EVP, Head of Preclinical Research & Clinical Development at
Generation Bio
January 2018 - March 2019
EVP Head of R & D, Chief Scientific Officer at
Generation Bio
August 2017 - January 2018
Global VP Neurology Development Lead at
SHIRE LIMITED
October 2015 - August 2017
Senior Director, Corporate Strategy and Portfolio Management at
Biogen
December 2014 - October 2015
Senior Medical Director Research and Development, Neurodegeneration at
Biogen
February 2013 - October 2015
Senior Medical Director at
Biogen
April 2013 - October 2014
Director, Neurology Research and Development at
BIOGEN IDEC INDIA
October 2010 - February 2013
Associate Director, Experimental Neurology at
Biogen
January 2008 - October 2010
Associate Professor at
Johns Hopkins Medicine
July 1999 - January 2008
Doug Kerr Md
Education
Northeastern University, Master Of Business Administration (Mba)
January 2012 - January 2014
Johns hopkins school of medicine
January 1996 - January 1999
Jefferson Health, Md/Phd
January 1988 - January 1995
January 1984 - January 1988
Frequently Asked Questions about Doug Kerr Md
What is Doug Kerr Md email address?
Doug Kerr Md's primary email address is *****@wearesrna.org. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Doug Kerr Md work for?
Doug Kerr Md is a Board Member and SAB at BlueRock Therapeutics, a company specializing in Commercial physical research.
Where Doug Kerr Md graduated from?
Doug Kerr Md holds a degree in Business Administration And Management from Northeastern University.
How can I directly contact Doug Kerr Md?
To contact Doug Kerr Md directly, you can use the email address *****@wearesrna.org. Complete contact information is available upon registration with Muraena.
Who is Doug Kerr Md?
Doug Kerr is a distinguished neurologist and neuroscientist based in Boston, Massachusetts, with over 14 years of experience in drug development across various stages. He holds an MD/PhD and an MBA, blending clinical expertise with business acumen. As a founding member of Generation Bio, he has played a pivotal role in advancing gene therapy initiatives. Doug's extensive background includes leadership roles in multiple biotech firms, where he has contributed to the development of innovative therapies for neurodegenerative diseases. He is also an active board member for several organizations, showcasing his commitment to both scientific progress and community engagement. His research interests encompass a wide range of fields, including biochemistry, immunology, and molecular biology, reflecting his multidisciplinary approach to neuroscience. Doug's publications highlight his contributions to understanding acute transverse myelitis and improving therapy development in ALS. He is passionate about leveraging scientific advancements to enhance patient outcomes and drive innovation in the life sciences sector.
Doug`s contact details
*****@wearesrna.org
*****@myelitis.org
*****@generationbio.com
*****@atlasventure.com
Colleagues
Vice President, Preclinical Development & Clinical Pharmacology
SVP Process & Analytical Development
Vice President, Assay Development
VP, Immunology
Vice President, Vendor Strategy & Partnerships
Vice President, GMP Manufacturing
Senior Vice President, Head of People & Culture
SVP, Global Head of Finance
Chief Scientific Officer
President and CEO